During the past decade, San Francisco AIDS Clinic / San Francisco Gen Hosp conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Francisco AIDS Clinic / San Francisco Gen Hosp" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 30 trials, followed by "University of California, San Francisco" with 2 trials sponsored, "Abbott" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Francisco AIDS Clinic / San Francisco Gen Hosp" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Glaxo Wellcome" with 3 trials as a collaborator, "Andrulis Pharmaceuticals" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Schering-Plough" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "San Francisco AIDS Clinic / San Francisco Gen Hosp" are "HIV Infections" (39 trials), "Cytomegalovirus Retinitis" (3 trials), "Lymphoma, Non-Hodgkin" (2 trials), "Pneumonia, Pneumocystis Carinii" (2 trials) and "Sarcoma, Kaposi" (2 trials). Many other conditions were trialed in "San Francisco AIDS Clinic / San Francisco Gen Hosp" in a lesser frequency.

Most popular intervention types in "San Francisco AIDS Clinic / San Francisco Gen Hosp" are "Drug" (34 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (15 trials), "Didanosine" (7 trials), "Indinavir sulfate" (5 trials), "Lamivudine" (4 trials) and "Nevirapine" (4 trials). Other intervention names were less common.

The vast majority of trials in "San Francisco AIDS Clinic / San Francisco Gen Hosp" are 37 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "San Francisco AIDS Clinic / San Francisco Gen Hosp". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in San Francisco AIDS Clinic / San Francisco Gen Hosp, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in San Francisco AIDS Clinic / San Francisco Gen Hosp, 9 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".